Key result
Thyrotropin receptor activation enhanced adipogenesis and was associated with higher expression of the BRITE marker CITED1 and the WAT marker LEPTIN.
Why the study?
Does TSHR activation enhance adipogenesis and modulate fat phenotype in human preadipocytes and neck fat?
Observational (n=44)
No
Does TSHR activation enhance adipogenesis and modulate fat phenotype in human preadipocytes and neck fat?
TSHR activation enhances adipogenesis and favors BRITE/pre-BAT formation, which may explain body composition changes and weight fluctuations in patients with Graves' disease.
Answers are grounded in this paper and cite their sources.
TSHR effects on adipogenesis remain preclinical; leaves open relevance to human fat phenotype or Graves' weight changes.
Evidence from clinical and experimental data suggests that thyrotropin receptor (TSHR) signalling is involved in energy expenditure through its impact on white (WAT) and brown (BAT) adipose tissues. TSHR expression increases during mesenchymal stem cell (MSC) differentiation into fat. We hypothesize that TSHR activation (TSHR*, elevated TSH, thyroid stimulating antibodies (TSAB) or activating mutation), influences MSC differentiation, which contributes to body composition changes seen in hypothyroidism or Graves’ disease (GD). The role of TSHR activation on adipogenesis was first investigated using ex vivo samples. Neck fat (all euthyroid at surgery) was obtained from GD (n=11, TSAB positive), Toxic Multinodular Goitre (TMNG, TSAB negative) (n=6) and control patients with benign euthyroid disease (n=11, TSAB negative). The effect of TSHR activation was then analysed using human primary abdominal subcutaneous preadipocytes (n=16). Cells were cultured in complete medium (CM) or adipogenic medium (ADM, containing thiazolidinedione (TZD), PPAR agonist, which is able to induce BAT formation) with or without TSHR activation (gain-of-function mutant) for 3 weeks. Adipogenesis was evaluated using oil red O (ORO), counting adipogenic foci, QPCR measurement of terminal differentiation marker (LPL). BAT (PGC-1α, UCP-1 & ZIC1), pre-BAT (PRDM16), BRITE- (CITED1) or WAT (LEPTIN) markers were analysed by semi-quantitative PCR or QPCR. In ex-vivo analysis there were no differences in the expression of UCP1, PGC1α and ZIC1. BRITE marker CITED1 levels were highest in GD followed by TMNG and control (p for trend=0.009). This was associated with higher WAT marker LEPTIN level in GD than the other 2 groups (p<0.001). In primary cell culture, TSHR activation substantially enhanced adipogenesis with 1.4±0.07 (ORO); 8.6±1.8 (foci) and 5.5±1.6 (LPL) fold increases compared with controls. Surprisingly TSHR activation in CM also significantly increased pre-BAT marker PRDM16, furthermore TZD-ADM induced adipogenesis showed substantially increased BAT markers, PGC-1α and UCP1. Our study revealed that TSHR activation plays an important role in the adipogenesis process and BRITE/pre-BAT formation, which leads to WAT or BAT phenotype. It may contribute to weight loss as heat during hyperthyroidism and later transforms into WAT post-treatment of GD when patients gain excess weight.
No takes yet. Share an insight, caveat, or question.
Draman et al. (2017) conducted an observational in Graves' disease and hyperthyroidism (n=44). Thyrotropin receptor (TSHR) activation vs. No TSHR activation (toxic multinodular goiter, benign controls, or empty vector) was evaluated on Expression of BRITE marker CITED1 in ex vivo neck fat (p=0.009). Thyrotropin receptor activation enhanced adipogenesis and was associated with higher expression of the BRITE marker CITED1 and the WAT marker LEPTIN.
Synapse has enriched 10 related papers. Consider them for comparative context: